NCT03875469 (PERCENT) is a NA clinical trial of Centargo injector (BPI 1000045) in Computed Tomography, sponsored by Bayer.

Who is sponsoring NCT03875469?

NCT03875469 is sponsored by Bayer.

What drugs are being tested in NCT03875469?

Interventions in NCT03875469: Centargo injector (BPI 1000045), Stellant MP injector.

What condition does NCT03875469 study?

NCT03875469 studies Computed Tomography.

Is NCT03875469 still recruiting?

NCT03875469 is currently completed. Last updated 3 March 2021.

Last reviewed 2021-03-03 · How we verify

NCT03875469: PERCENT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study to Test the Usability of a New Injector to Administer Contrast Media Into Humans for Diagnostic Purposes

Completed NA Last updated 3 March 2021

What this trial tests

NA trial testing Centargo injector (BPI 1000045) in Computed Tomography in 425 participants. Completed in 10 March 2020.

Timeline

21 June 2019

Primary endpoint
10 March 2020

10 March 2020

Quick facts

Lead sponsor	Bayer
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	425
Start date	21 June 2019
Primary completion	10 March 2020
Estimated completion	10 March 2020
Sites	2 locations across Netherlands, Australia

Drugs / interventions tested

Centargo injector (BPI 1000045)
Stellant MP injector

Conditions studied

Computed Tomography — all drugs for Computed Tomography →

Sponsor

Bayer — full company profile →

Who can join

18 and older, any sex, with Computed Tomography. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study investigates if a new medical device, which injects contrast media and flushing solution into humans to increase the visibility of images taken of the human body for diagnostic purposes, is easier to handle, quicker and cheaper than an older injector.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Performance of Centargo: A Novel Piston-Based Injection System for High Throughput in CE CT.
Kemper CA, Mihl C, Martens B, McDermott MC, et al · · 2022 · cited 2× · PMID 35411194 · DOI 10.2147/mder.s353221

Verify or expand the search:

Other recruiting trials for Computed Tomography

Currently open trials in the same condition.

NCT07291609 — Microplastics and Nanoplastics in Patients With Chronic Coronary Syndromes · recruiting
NCT06971042 — Early Diagnosis of ARDS in Mechanically Ventilated Patient Using LUS Score in Comparison With CT · recruiting
NCT06509087 — The Combined Utility of Angio-CT and MRI in Managing Chronic Musculoskeletal Pain: a Prospective Study to Evaluate the E · recruiting
NCT06951126 — CT Prediction for Transcatheter Tricuspid Interventions · recruiting
NCT04989439 — Comparison of Computertomography Scan, Electrical Impedance Tomography, and Ultrasound of the Lung in Infants · recruiting

Other Bayer trials

Trials by the same sponsor.

NCT05900388 — A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolis · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT05477953 — An Observational Pregnancy Safety Study in Women Who Were Exposed to the Drug Nifurtimox During Pregnancy to Learn About · not yet recruiting
NCT07192952 — A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child · Phase 3 · not yet recruiting
NCT07450599 — A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Befo · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03875469 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bayer
Last refreshed: 3 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03875469.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing